Papers: 5 Sep 2014 - 12 Sep 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis. Jons D, Sundström P, Andersen O Acta Neurol Scand. 2014 Sep 11. Epub 1969 Dec 31. PMID: 25208981. Abstract Editors' Pick What explains functioning from the perspective of people with multiple sclerosis? Conrad A, Coenen M, Kesselring J, Cieza A J Neurol. 2014 Sep 11. Epub 2014 Sep 11. PMID: 25209852. Abstract Optimal design of clinical trials with biologics using dose-time-response models. Lange MR, Schmidli H Stat Med. 2014 Sep 10. PMID: 25209423. Abstract Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report. de Andrade A C D V, Brito E A, Harris O M O, de Andrade A P D V, Leite M F, Pithon M M Int J Dermatol. 2014 Sep 10. PMID: 25208461. Abstract Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131). Sormani M Eur J Neurol. 2014 Oct; 21(10):e84. PMID: 25209064. Abstract Multiple sclerosis and seizures: incidence and prevalence over 40 years. Lund C, Nakken KO, Edland A, Celius EG Acta Neurol Scand. 2014 Sep 10. PMID: 25209977. Abstract Experimental Autoimmune Encephalomyelitis in Marmosets. Jagessar AS, Dijkman K, Dunham J, 't Hart BA, Kap YS Methods Mol Biol. 2014 Sep 11. PMID: 25208751. Abstract Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial. Kehoe M, Saunders J, Jakeman P, Coote S Mult Scler. 2014 Sep 10. PMID: 25209170. Abstract How do corticosteroids influence myelin genesis in the central nervous system? Chari DM Neural Regen Res. 2014 May 1; 9(9):909-11. PMID: 25206910. Abstract Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage. Ke L, Guo W, Xu J, Zhang G, Wang W, Huang W Neural Regen Res. 2014 Feb 1; 9(3):252-9. PMID: 25206809. Abstract Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function. Li Q, Dong C, Li W, Bu W, Wu J, Zhao W Neural Regen Res. 2014 May 1; 9(9):959-67. PMID: 25206918. Abstract Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis. Yarnykh VL, Bowen JD, Samsonov A, Repovic P, Mayadev A, Qian P, Gangadharan B, Keogh BP, Maravilla KR, Henson L JK Radiology. 2014 Sep 10:140528. PMID: 25208343. Abstract The Olig family affects central nervous system development and disease. Tan B, Yu J, Yin Y, Jia G, Jiang W, Yu L Neural Regen Res. 2014 Feb 1; 9(3):329-36. PMID: 25206819. Abstract Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy. Ota K, Obayashi M, Ozaki K, Ichinose S, Kakita A, Tada M, Takahashi H, Ando N, Eishi Y, Mizusawa H, et al. Acta Neuropathol Commun. 2014 Sep 11; 2(1):136. Epub 2014 Sep 11. PMID: 25208467. Abstract Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability. Min J-H, Waters P, Vincent A, Cho H-J, Joo B-E, Woo S-Y, Lee S-Y, Shin H-Y, Lee K H, Kim B J PLoS One. 2014; 9(9):e107274. Epub 2014 Sep 11. PMID: 25211011. Abstract Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients. Müller T, Barghorn S, Lütge S, Haas T, Mueller R, Gerlach B, Ohm G, Eilert K, Trommer I, Mueller BK J Neural Transm. 2014 Sep 11. Epub 2014 Sep 11. PMID: 25209051. Abstract Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients. Cevik B, Yigit S, Karakus N, Aksoy D, Kurt S, Ates O J Investig Med. 2014 Sep 8. PMID: 25203152. Abstract Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply. Frohman EM, Douek D, Major EO JAMA Neurol. 2014 Sep 1; 71(9):1192-3. PMID: 25200546. Abstract Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis. Warnke C, Adams O, Kieseier B JAMA Neurol. 2014 Sep 1; 71(9):1192. PMID: 25200545. Abstract Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system. Höer A, Schiffhorst G, Zimmermann A, Fischaleck J, Gehrmann L, Ahrens H, Carl G, Sigel K-O, Osowski U, Klein M, et al. BMC Health Serv Res. 2014; 14(1):381. Epub 2014 Sep 10. PMID: 25209585. Abstract IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient. Crestani E, Lee J, Gorman M, Castells M, Dioun A Pediatr Allergy Immunol. 2014 Sep 9. PMID: 25200765. Abstract Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ Neurology. 2014 Sep 9; 83(11):1022-4. PMID: 25200713. Abstract Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine. Abbaszadeh H-A, Tiraihi T, Delshad AR, Saghedizadeh M, Taheri T, Kazemi H, Hassoun HK Tissue Cell. 2014 Aug 20. PMID: 25200619. Abstract Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides. Rozenblum G T, Kaufman T, Vitullo A D Mol Ther Nucleic Acids. 2014; 3:e192. PMID: 25202925. Abstract Multiple sclerosis: a review of the disease and treatment options. Sturm D, Gurevitz SL, Turner A Consult Pharm. 2014; 29(7):469-79. PMID: 25203107. Abstract In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance. da Cunha AP, Wu HY, Rezende RM, Vandeventer T, Weiner HL Int Immunol. 2014 Sep 6. PMID: 25194146. Abstract Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future. Steinman L Rev Neurol (Paris). 2014 Sep 2. PMID: 25193013. Abstract Molecular mechanisms of scar-sourced axon growth inhibitors. Ohtake Y, Li S Brain Res. 2014 Sep 1. PMID: 25192646. Abstract Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β Lynch MA Brain Res. 2014 Sep 2. PMID: 25193603. Abstract Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort. Carvalho A T, Abreu P, Sá M J Acta Med Port. 2014 Jul-Aug; 27(4):437-43. Epub 2014 Aug 29. PMID: 25203951. Abstract [Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"]. de Sá J Acta Med Port. 2014 Jul-Aug; 27(4):409-10. Epub 2014 Aug 29. PMID: 25203944. Abstract
Editors' Pick Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis. Jons D, Sundström P, Andersen O Acta Neurol Scand. 2014 Sep 11. Epub 1969 Dec 31. PMID: 25208981. Abstract
Editors' Pick What explains functioning from the perspective of people with multiple sclerosis? Conrad A, Coenen M, Kesselring J, Cieza A J Neurol. 2014 Sep 11. Epub 2014 Sep 11. PMID: 25209852. Abstract
Optimal design of clinical trials with biologics using dose-time-response models. Lange MR, Schmidli H Stat Med. 2014 Sep 10. PMID: 25209423. Abstract
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report. de Andrade A C D V, Brito E A, Harris O M O, de Andrade A P D V, Leite M F, Pithon M M Int J Dermatol. 2014 Sep 10. PMID: 25208461. Abstract
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131). Sormani M Eur J Neurol. 2014 Oct; 21(10):e84. PMID: 25209064. Abstract
Multiple sclerosis and seizures: incidence and prevalence over 40 years. Lund C, Nakken KO, Edland A, Celius EG Acta Neurol Scand. 2014 Sep 10. PMID: 25209977. Abstract
Experimental Autoimmune Encephalomyelitis in Marmosets. Jagessar AS, Dijkman K, Dunham J, 't Hart BA, Kap YS Methods Mol Biol. 2014 Sep 11. PMID: 25208751. Abstract
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial. Kehoe M, Saunders J, Jakeman P, Coote S Mult Scler. 2014 Sep 10. PMID: 25209170. Abstract
How do corticosteroids influence myelin genesis in the central nervous system? Chari DM Neural Regen Res. 2014 May 1; 9(9):909-11. PMID: 25206910. Abstract
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage. Ke L, Guo W, Xu J, Zhang G, Wang W, Huang W Neural Regen Res. 2014 Feb 1; 9(3):252-9. PMID: 25206809. Abstract
Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function. Li Q, Dong C, Li W, Bu W, Wu J, Zhao W Neural Regen Res. 2014 May 1; 9(9):959-67. PMID: 25206918. Abstract
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis. Yarnykh VL, Bowen JD, Samsonov A, Repovic P, Mayadev A, Qian P, Gangadharan B, Keogh BP, Maravilla KR, Henson L JK Radiology. 2014 Sep 10:140528. PMID: 25208343. Abstract
The Olig family affects central nervous system development and disease. Tan B, Yu J, Yin Y, Jia G, Jiang W, Yu L Neural Regen Res. 2014 Feb 1; 9(3):329-36. PMID: 25206819. Abstract
Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy. Ota K, Obayashi M, Ozaki K, Ichinose S, Kakita A, Tada M, Takahashi H, Ando N, Eishi Y, Mizusawa H, et al. Acta Neuropathol Commun. 2014 Sep 11; 2(1):136. Epub 2014 Sep 11. PMID: 25208467. Abstract
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability. Min J-H, Waters P, Vincent A, Cho H-J, Joo B-E, Woo S-Y, Lee S-Y, Shin H-Y, Lee K H, Kim B J PLoS One. 2014; 9(9):e107274. Epub 2014 Sep 11. PMID: 25211011. Abstract
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients. Müller T, Barghorn S, Lütge S, Haas T, Mueller R, Gerlach B, Ohm G, Eilert K, Trommer I, Mueller BK J Neural Transm. 2014 Sep 11. Epub 2014 Sep 11. PMID: 25209051. Abstract
Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients. Cevik B, Yigit S, Karakus N, Aksoy D, Kurt S, Ates O J Investig Med. 2014 Sep 8. PMID: 25203152. Abstract
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply. Frohman EM, Douek D, Major EO JAMA Neurol. 2014 Sep 1; 71(9):1192-3. PMID: 25200546. Abstract
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis. Warnke C, Adams O, Kieseier B JAMA Neurol. 2014 Sep 1; 71(9):1192. PMID: 25200545. Abstract
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system. Höer A, Schiffhorst G, Zimmermann A, Fischaleck J, Gehrmann L, Ahrens H, Carl G, Sigel K-O, Osowski U, Klein M, et al. BMC Health Serv Res. 2014; 14(1):381. Epub 2014 Sep 10. PMID: 25209585. Abstract
IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient. Crestani E, Lee J, Gorman M, Castells M, Dioun A Pediatr Allergy Immunol. 2014 Sep 9. PMID: 25200765. Abstract
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ Neurology. 2014 Sep 9; 83(11):1022-4. PMID: 25200713. Abstract
Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine. Abbaszadeh H-A, Tiraihi T, Delshad AR, Saghedizadeh M, Taheri T, Kazemi H, Hassoun HK Tissue Cell. 2014 Aug 20. PMID: 25200619. Abstract
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides. Rozenblum G T, Kaufman T, Vitullo A D Mol Ther Nucleic Acids. 2014; 3:e192. PMID: 25202925. Abstract
Multiple sclerosis: a review of the disease and treatment options. Sturm D, Gurevitz SL, Turner A Consult Pharm. 2014; 29(7):469-79. PMID: 25203107. Abstract
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance. da Cunha AP, Wu HY, Rezende RM, Vandeventer T, Weiner HL Int Immunol. 2014 Sep 6. PMID: 25194146. Abstract
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future. Steinman L Rev Neurol (Paris). 2014 Sep 2. PMID: 25193013. Abstract
Molecular mechanisms of scar-sourced axon growth inhibitors. Ohtake Y, Li S Brain Res. 2014 Sep 1. PMID: 25192646. Abstract
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β Lynch MA Brain Res. 2014 Sep 2. PMID: 25193603. Abstract
Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort. Carvalho A T, Abreu P, Sá M J Acta Med Port. 2014 Jul-Aug; 27(4):437-43. Epub 2014 Aug 29. PMID: 25203951. Abstract
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"]. de Sá J Acta Med Port. 2014 Jul-Aug; 27(4):409-10. Epub 2014 Aug 29. PMID: 25203944. Abstract